<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:newstin="http://newstin.com/rss/module" xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/" version="2.0">
  <channel>
    <title>Newstin - Protherics</title>
    <link>http://www.newstin.co.uk/uk/PROTHERICS</link>
    <description>Organizing the News</description>
    <copyright>Copyright © 2006 I2S a.s.</copyright>
    <dc:rights>Copyright © 2006 I2S a.s.</dc:rights>
    <item>
      <title>Protherics - News</title>
      <link>http://www.newstin.co.uk/uk/PROTHERICS</link>
      <description>You are currently using FREE feeds from Newstin. You will get more data and services with Newstin Pro RSS licensed subscription.&lt;br/&gt;Newstin Pro RSS provides aggregated and categorized news content covering 1.25 Million news categories from 160.000 online sources in the format that can be easily integrated into environment or software of your choice. &lt;a href="http://corp.newstin.com/static.a?tpl=corp_rss"&gt;Read more about Newstin Pro RSS&lt;/a&gt; or &lt;a href="http://corp.newstin.com/files/corp/newstin_prorss.pdf"&gt;download the product presentation now&lt;/a&gt;.</description>
      <pubDate>Mon, 09 Nov 2009 00:15:09 GMT</pubDate>
      <guid>http://www.newstin.co.uk/uk/PROTHERICS</guid>
      <dc:date>2009-11-09T00:15:09Z</dc:date>
    </item>
    <item>
      <title>Drug group acquisition boosts BTG</title>
      <link />
      <description />
      <pubDate>Fri, 06 Nov 2009 05:14:54 GMT</pubDate>
      <guid />
      <dc:date>2009-11-06T05:14:54Z</dc:date>
    </item>
    <item>
      <title>BTG hit by lower sales of snakebite antidote</title>
      <link />
      <description />
      <pubDate>Thu, 05 Nov 2009 15:07:30 GMT</pubDate>
      <guid />
      <dc:date>2009-11-05T15:07:30Z</dc:date>
    </item>
    <item>
      <title>Unilever's quality is hard to beat, buy in</title>
      <link />
      <description />
      <pubDate>Fri, 06 Nov 2009 00:00:01 GMT</pubDate>
      <guid />
      <dc:date>2009-11-06T00:00:01Z</dc:date>
    </item>
    <item>
      <title>Biotech survivors to buy now</title>
      <link />
      <description />
      <pubDate>Fri, 02 Oct 2009 06:26:37 GMT</pubDate>
      <guid />
      <dc:date>2009-10-02T06:26:37Z</dc:date>
    </item>
    <item>
      <title>Novartis buys HySolv technology from BTG</title>
      <link />
      <description />
      <pubDate>Wed, 02 Sep 2009 11:01:51 GMT</pubDate>
      <guid />
      <dc:date>2009-09-02T11:01:51Z</dc:date>
    </item>
    <item>
      <title>Forest Laboratories and AstraZeneca to Co-Develop and Commercialize a Late Stage Next Generation...</title>
      <link />
      <description />
      <pubDate>Wed, 12 Aug 2009 08:01:00 GMT</pubDate>
      <guid />
      <dc:date>2009-08-12T08:01:00Z</dc:date>
    </item>
    <item>
      <title>Mortality rates higher in hepatitis C virus carriers</title>
      <link />
      <description />
      <pubDate>Fri, 31 Jul 2009 12:30:00 GMT</pubDate>
      <guid />
      <dc:date>2009-07-31T12:30:00Z</dc:date>
    </item>
    <item>
      <title>MARKET REPORT: Taking a gamble on biotechs cure</title>
      <link />
      <description />
      <pubDate>Wed, 29 Jul 2009 21:45:04 GMT</pubDate>
      <guid />
      <dc:date>2009-07-29T21:45:04Z</dc:date>
    </item>
    <item>
      <title>UPDATE 1-AstraZeneca to push ahead with BTG sepsis drug</title>
      <link />
      <description />
      <pubDate>Wed, 29 Jul 2009 08:47:00 GMT</pubDate>
      <guid />
      <dc:date>2009-07-29T08:47:00Z</dc:date>
    </item>
  </channel>
</rss>

